Skip to content

Convalescent plasma players rally on FDA emergency use nod

August 24, 2020

Immunoglobulin therapy providers are in the green premarket on the heels of the FDA nod for emergency use of convalescent plasma for COVID-19.

Kamada (NASDAQ:KMDA) (+23%), Grifols (NASDAQ:GRFS) (+6%), XBiotech (NASDAQ:XBIT) (+9%), Cerus (NASDAQ:CERS) (+20%), ADMA Biologics (NASDAQ:ADMA) (+70%)

https://seekingalpha.com/news/3608072-convalescent-plasma-players-rally-on-fda-emergency-use-nod

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: